China Pharma Holdings (CPHI) Intangibles (2010 - 2026)

China Pharma Holdings' Intangibles history runs 17 years deep, the most recent figure standing at $38.7 million for Q1 2026.

• Quarterly Intangibles rose 488.66% year-over-year to $38.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.7 million (up 488.66% YoY) and the FY2025 annual result came in at $24.1 million, up 273.64% from the prior year.
• Intangibles was $38.7 million for Q1 2026 at China Pharma Holdings, up from $24.1 million in the prior quarter.
• Across five years, Intangibles topped out at $38.7 million in Q1 2026 and bottomed at $106788.0 in Q3 2022.
• A 5-year average of $6.7 million and a median of $4.4 million in 2024 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles slumped 97.95% — and 2023, when it jumped 1437.96%.
• China Pharma Holdings' Intangibles stood at $1.8 million in 2022, then jumped by 80.1% to $3.3 million in 2023, then soared by 97.97% to $6.4 million in 2024, then surged by 273.64% to $24.1 million in 2025, then jumped by 60.61% to $38.7 million in 2026.
• Business Quant data shows CPHI's Intangibles at $38.7 million in Q1 2026, $24.1 million in Q4 2025, and $8.4 million in Q3 2025.